Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCRESOL
Stock Latest News
Private Companies
Resolution Therapeutics Highlights Clinical Progress in Regenerative Macrophage Therapy
3h ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Clinical Presence and ESLD Program at Major Hepatology Meeting
9h ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Clinical and Operational Momentum Ahead of EMERALD Trial Milestone
6d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Progress of EMERALD Trial and Upcoming Data Milestone
10d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights Upcoming EMERALD Trial Milestone and Conference Engagement
10d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Momentum Ahead of Key EMERALD Trial Readout
13d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights EMERALD Trial and RTX001 in Liver Disease Program
14d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights EMERALD Trial as Potential New Approach in End-Stage Liver Disease
14d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Clinical, Operational, and IP Momentum Ahead of EMERALD Data
20d ago
RESOL
Premium
Private Companies
Industry Recognition Underscores Resolution Therapeutics’ IP Leadership
21d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights RTX001 Progress and Upcoming EMERALD Trial Milestone
22d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights RTX001 Progress and Upcoming EMERALD Trial Milestone
22d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Strengthens Leadership and Clinical Momentum Ahead of EMERALD Data
27d ago
RESOL
Premium
Private Companies
Resolution Therapeutics Adds Veteran Operations Leader as RTX001 Trial Advances
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Bolsters Operations Leadership Amid EMERALD Trial Progress
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Clinical and Industry Momentum as EMERALD Trial Nears Key Data Milestone
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights EMERALD Trial Targeting End-Stage Liver Disease
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights EMERALD Trial Progress and Interim Data Timeline
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Highlights EMERALD Trial Progress and Regenerative Macrophage Focus
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Builds Momentum as EMERALD Liver Cell Therapy Trial Gains Recognition
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics Gains Industry Recognition as EMERALD Trial Progresses
1M ago
RESOL
Premium
Private Companies
Resolution Therapeutics’ RTX001 Program Recognized as EMERALD Trial Progresses
1M ago
RESOL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
